Unconventional secretory pathway activation restores hair cell mechanotransduction in an USH3A model

Abstract

The pathogenic variant c.144T>G (p.N48K) in the clarin1 gene (<i>CLRN1</i>) results in progressive loss of vision and hearing in Usher syndrome IIIA (USH3A) patients. CLRN1 is predicted to be an essential protein in hair bundles, the mechanosensory structure of hair cells critical for hearing and balance. When expressed in animal models, CLRN1 localizes to the hair bundle, whereas glycosylation-deficient CLRN1^N48K aggregates in the endoplasmic reticulum, with only a fraction reaching the bundle. We hypothesized that the small amount of CLRN1^N48K that reaches the hair bundle does so via an unconventional secretory pathway and that activation of this pathway could be therapeutic. Using genetic and pharmacological approaches, we find that clarin1 knockout (<i>clrn1</i>^<i>KO/KO</i> ) zebrafish that express the <i>CLRN1</i>^{<i>c.144T>G</i>} pathogenic variant display progressive hair cell dysfunction, and that CLRN1^N48K is trafficked to the hair bundle via the GRASP55 cargo-dependent unconventional secretory pathway (GCUSP). On expression of <i>GRASP55</i> mRNA, or on exposure to the drug artemisinin (which activates GCUSP), the localization of CLRN1^N48K to the hair bundles was enhanced. Artemisinin treatment also effectively restored hair cell mechanotransduction and attenuated progressive hair cell dysfunction in <i>clrn1</i>^<i>KO/KO</i> larvae that express <i>CLRN1</i>^{<i>c.144T>G</i>} , highlighting the potential of artemisinin to prevent sensory loss in <i>CLRN1</i>^{<i>c.144T>G</i>} patients.